FDA campaign H-0394-2025
Class IHazard
Listeria monocytogenes. During routine testing the firm received positive test results for Listeria monocytogenes.
Distribution
Product was shipped to the following: Distribution Center Shipped to: AR, AZ, CO, KS, IL, IN, MN, TX Distribution Centers Provided to these states: AL, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, LA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, PA, PR, SC, SD, TN, TX, UT, VA, WI, WV, WY
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.